113 related articles for article (PubMed ID: 4050978)
1. The effects of 1-oleoyl-2-acetylglycerol on platelet protein phosphorylation and platelet ultrastructure.
Friesen LL; Gerrard JM
Am J Pathol; 1985 Oct; 121(1):79-87. PubMed ID: 4050978
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphorylation and platelet secretion.
Gerrard JM; Israels SJ; Friesen LL
Nouv Rev Fr Hematol (1978); 1985; 27(4):267-73. PubMed ID: 4059047
[TBL] [Abstract][Full Text] [Related]
3. Differences in the mode of action of 1-oleoyl-2-acetyl-glycerol and phorbol ester in platelet activation.
Ashby B; Kowalska MA; Wernick E; Rigmaiden M; Daniel JL; Smith JB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):473-83. PubMed ID: 2999204
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase blockers: new platelet activation inhibitors.
Rendu F; Eldor A; Grelac F; Levy-Toledano S; Levitzki A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):713-6. PubMed ID: 2133252
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thrombin-induced platelet activation by dioctanoylglycerol pretreatment is not correlated with the 47 kDa protein phosphorylation.
Ruzzene M; Francesconi M; Cavallini L; Battistella L; Deana R
Second Messengers Phosphoproteins; 1992; 14(1-2):11-9. PubMed ID: 1403847
[TBL] [Abstract][Full Text] [Related]
6. Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR1 activating peptide.
Missy K; Plantavid M; Pacaud P; Viala C; Chap H; Payrastre B
Thromb Haemost; 2001 Mar; 85(3):514-20. PubMed ID: 11307824
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of calpain dependent phosphorylation of myosin light chain in human platelets.
Kajiwara Y; Tsujinaka T; Sakon M; Kambayashi J; Ohshiro T; Murachi T; Mori T
Biochem Int; 1987 Nov; 15(5):935-44. PubMed ID: 2829910
[TBL] [Abstract][Full Text] [Related]
8. Studies on platelet protein phosphorylation in patients with impaired responses to platelet agonists.
Speiser-Ellerton S; Weiss HJ
J Lab Clin Med; 1990 Jan; 115(1):104-11. PubMed ID: 2105365
[TBL] [Abstract][Full Text] [Related]
9. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
Chen R; Liang N
Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
[TBL] [Abstract][Full Text] [Related]
10. Platelet protein phosphorylation.
Gerrard JM; Friesen LL; McCrea JM; Israels SJ; Robinson P
Adv Exp Med Biol; 1985; 192():235-48. PubMed ID: 3010667
[TBL] [Abstract][Full Text] [Related]
11. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
Rendu F; Bachelot C; Molle D; Caen J; Guez D
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
[TBL] [Abstract][Full Text] [Related]
12. Response of aequorin-loaded platelets to activators of protein kinase C.
Ware JA; Saitoh M; Smith M; Johnson PC; Salzman EW
Am J Physiol; 1989 Jan; 256(1 Pt 1):C35-43. PubMed ID: 2912135
[TBL] [Abstract][Full Text] [Related]
13. Thrombin-induced activation of RhoA in platelet shape change.
Bodie SL; Ford I; Greaves M; Nixon GF
Biochem Biophys Res Commun; 2001 Sep; 287(1):71-6. PubMed ID: 11549255
[TBL] [Abstract][Full Text] [Related]
14. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
15. Further characterization of human platelet activation in the absence of aggregation: phosphorylations of specific proteins and relationship with platelet secretion.
Nunez D; Levy-Toledano S
Thromb Haemost; 1984 Apr; 51(2):198-203. PubMed ID: 6429882
[TBL] [Abstract][Full Text] [Related]
16. Increase in cell responses and protein phosphorylation of neutrophils induced by synthetic diacylglycerols.
Kawada M; Edashige K; Watanabe Y; Yasuda T; Utsumi K
Physiol Chem Phys Med NMR; 1993; 25(4):237-52. PubMed ID: 8153150
[TBL] [Abstract][Full Text] [Related]
17. Exogenous sn-1,2-diacylglycerols containing saturated fatty acids function as bioregulators of protein kinase C in human platelets.
Lapetina EG; Reep B; Ganong BR; Bell RM
J Biol Chem; 1985 Feb; 260(3):1358-61. PubMed ID: 3155733
[TBL] [Abstract][Full Text] [Related]
18. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
19. Phosphotyrosine proteins in platelets from patients with storage pool disease: direct relation between granule defects and defective signal transduction.
Arderiu G; Díaz-Ricart M; Domenech P; Escolar G; Ordinas A; Pujol-Moix N
Haematologica; 2002 Jun; 87(6):629-36. PubMed ID: 12031920
[TBL] [Abstract][Full Text] [Related]
20. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation.
Garcia JG; Davis HW; Patterson CE
J Cell Physiol; 1995 Jun; 163(3):510-22. PubMed ID: 7775594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
